Detalhe da pesquisa
1.
Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: does it help tailor adjuvant treatment?
Ann Oncol
; 35(5): 409-411, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484973
2.
Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.
Support Care Cancer
; 27(4): 1163-1170, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610431
3.
ctDNA as a predictive biomarker in advanced breast cancer: Lessons from the MONALEESA studies.
Ann Oncol
; 34(11): 955-959, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996168
4.
Liquid biopsy accelerates precision medicine.
Ann Oncol
; 34(4): 333-335, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804455
5.
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.
Ann Oncol
; 29(4): 895-902, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365031
6.
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
Ann Oncol
; 29(1): 237-243, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045555
7.
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.
Ann Oncol
; 29(8): 1777-1783, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893791
8.
Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: lessons from the PEARL study.
Ann Oncol
; 32(4): 427-430, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33571637
9.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
Ann Oncol
; 26(2): 259-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25214542
10.
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
Ann Oncol
; 25(12): 2304-2313, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336116
11.
Patient-reported outcomes and genomic signatures: tools to tailor adjuvant endocrine treatment?
Ann Oncol
; 30(11): 1677-1681, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31613310
12.
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.
Ann Oncol
; 25(10): 1959-1965, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185240
13.
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
ESMO Open
; 9(3): 102390, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460249
14.
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting.
Br J Cancer
; 108(6): 1358-67, 2013 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23470469
15.
CDK4/6 inhibitors as neoadjuvant treatment in breast cancer-what can we learn?
Ann Oncol
; 29(12): 2274-2278, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30304385
16.
Genomic grade adds prognostic value in invasive lobular carcinoma.
Ann Oncol
; 24(2): 377-384, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23028037
17.
How I treat endocrine-dependent metastatic breast cancer.
ESMO Open
; 8(2): 100882, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806375
18.
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.
ESMO Open
; 7(6): 100610, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356416
19.
St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists.
Ann Oncol
; 26(8): 1519-20, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26063634
20.
Understanding the molecular basis of histologic grade.
Pathobiology
; 75(2): 104-11, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18544965